Illumina, Inc. (ILMN): Officer sold ~$71K

~$71K

Approx. value · 549 sh @ $129.27

11K

Holds after · shares reported

Traded

Dec 8, 2025

Filed

Dec 9, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 28, 2025FDARecall: Reagent Kits/ containing flow cells, components of NextSeq 550Dx Instrument: NextSeq 550Dx High Output Reagent Kit v2.5 (75 cycles) IVD, REF: 20028870/NextSeq…
2. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
3. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
4. Oct 31, 2025CongressDisclosed sale of ILMN — reported range $1,001 - $15,000
5. Nov 3, 2025Insider · Their first buy on recordDirector purchased ~$61K of ILMN shares in the open market
6. Nov 5, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 4 employees
7. Nov 6, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 28 employees
8. Nov 13, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 8 employees
9. Nov 13, 20255% stakeCapital World Investors reported a passive stake (13G) of 13.2%
10. Nov 20, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 7 employees
11. Dec 4, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 3 employees
12. Dec 8, 2025 · this disclosureInsiderOfficer sold ~$71K of ILMN shares in the open market

What came next

1. Dec 11, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 7 employees
2. Dec 12, 2025InsiderOfficer sold ~$44K of ILMN shares in the open market
3. Dec 22, 2025Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 1 employees
4. Jan 8, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 4, 2026, Everett Cunningham, Chief Commercial Officer, notified Illumina, Inc. that he will be resigning effective as of January 16, 2026.”
5. Jan 13, 2026Company filing · Form 8-K · ResultsReported its results
6. Jan 14, 2026Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 1 employees
7. Jan 14, 2026Layoff notice · 5200 Illumina Way San Diego CA 92122Layoff notice filed in CA: 4 employees
8. Jan 30, 2026Company filing · Form 8-K · Acquisition or sale, Other newsCompleted buying or selling a business or assets, and reported other company news“As previously disclosed in the Current Report on Form 8-K filed by Illumina, Inc. (the “Company”) with the Securities and Exchange Commission (the “SEC”) on June 23, 2025, the Company entered into a Stock Purchase Agreement, dated as of June 22, 2025 (the “Purchase Agreement”), with Standard BioTools Inc. (“Standard BioTools”), a Delaware corporation, pursuant to which the Company agreed to acquire (the…”
9. Feb 5, 2026Company filing · Form 8-K · ResultsReported its results
10. Feb 6, 2026Federal contract · $502K obligatedDepartment of Agriculture awarded Illumina, Inc.: $502K obligated to date
11. Feb 9, 2026InsiderDirector purchased ~$24K of ILMN shares in the open market
12. Feb 10, 2026CongressDisclosed purchase of ILMN — reported range $1,001 - $15,000
13. Feb 18, 2026InsiderOfficer sold ~$275K of ILMN shares in the open market
14. Feb 19, 2026Government · Federal Register noticeGranting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
15. Feb 20, 2026InsiderOfficer sold ~$155K of ILMN shares in the open market
16. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
17. Apr 2, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Frances Arnold, Robert S. Epstein and Gary S. Guthart notified the Board of Directors (the "Board") of Illumina, Inc. (the "Company") of her or his intention to retire as a director of the Company, effective as of May 21, 2026 (the date of the Company’s 2026 annual meeting of stockholders).”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Illumina, Inc.

For Illumina, Inc., OQRO holds 93 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 2 fund holdings reports (13F) and 4 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ILMN page.

Other recent filings by Christensen Jakob Wedel, SVP, Strategy/Corp Development

• SEC Form 4 at Illumina, Inc. (ILMN)Aug 20, 2026
• SEC Form 4 at Illumina, Inc. (ILMN)May 7, 2026

The full history of Christensen Jakob Wedel, SVP, Strategy/Corp Development is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Illumina, Inc.

• SEC Form 13F-HRNov 13, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 12, 2026

Everything OQRO holds on this company is on its ILMN page.